Search results for Bayer - Clinical Trials Registry - ICH GCP

Example: Heart Attack

Clinical Trials Sponsored by Bayer

Total 2194 results

NCT05515432

Recruiting

A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

Conditions: Chronic Kidney Disease, Renal Impairment, Healthy Volunteers
NCT05477953

Recruiting

An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health

Conditions: Chagas Disease
NCT05171387

Recruiting

Darolutamide + Androgen Deprivation Therapy (ADT) Compared With ADT Alone, for Chinese Men With High Risk, Nonmetastatic Prostate Cancer

Conditions: Prostate Cancer
NCT02759419

Recruiting

A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

Conditions: Hypertension, Pulmonary
NCT03890731

Enrolling by invitation

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Conditions: Solid Cancer
NCT05217914

Active, not recruiting

A Study to Learn More About Copanlisib Treatment Patterns in People With Indolent Non-Hodgkin Lymphoma, a Type of Cancer That Grows and Spread Slowly and Develops in the Lymphatic System (a Part of Immune System) in Taiwan Under Real-word Conditions

Conditions: Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
NCT04809805

Active, not recruiting

A Study to Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced Cancer

Conditions: Metastatic Melanoma and Other Solid Tumors
NCT03439891

Active, not recruiting

Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer

Conditions: Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v7, Stage IIIC Hepatocellular Carcinoma AJCC v7, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8
NCT02626455

Active, not recruiting

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Conditions: Lymphoma, Non-Hodgkin
NCT05086952

Completed

A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance Immediately

Conditions: Heart Failure, Children
NCT04085458

Completed

Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophila A (Post-marketing Investigation)

Conditions: Hemophilia A
NCT05457283

Recruiting

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Conditions: Chronic Kidney Disease, Proteinuria, Children
NCT05452889

Recruiting

PET Image in PAH Patients

Conditions: Pulmonary Arterial Hypertension
NCT03215511

Active, not recruiting

A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Conditions: Solid Tumors Harboring NTRK Fusion
NCT05481528

Recruiting

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes, Healthy Volunteers
NCT05301062

Recruiting

A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels

Conditions: Metastatic Castration-resistant Prostate Cancer, Bone Metastases
NCT05254002

Recruiting

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease
NCT04722991

Recruiting

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Conditions: Diabetic Retinopathy
NCT04609943

Recruiting

Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)

Conditions: Acute Respiratory Distress Syndrome
NCT04565236

Recruiting

A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A

Conditions: Hemophilia A
NCT04136353

Recruiting

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Conditions: Prostate Cancer
NCT02637687

Recruiting

A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children

Conditions: Solid Tumors Harboring NTRK Fusion
NCT05407662

Active, not recruiting

A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus, Heart Failure
NCT05150938

Active, not recruiting

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Conditions: Treatment of Venous Thromboembolism in Cancer Patients
NCT04423718

Active, not recruiting

Study to Gather Information on Safety and Use of High Dose Aflibercept Injection Into the Eye in Patients With an Age Related Eye Disorder That Causes Blurred Vision or a Blind Spot Due to Abnormal Blood Vessels That Leak Fluid Into the Light Sensitive Lining Inside the Eye

Conditions: Neovascular Age-Related Macular Degeneration